Epstein; Joseph William

Patent Applications and Registrations

Patent applications and USPTO patent grants for Epstein; Joseph William.The latest application filed is for "2-pyridinyl[7-(substituted-pyridin-4-yl) pyrazolo[1,5-a]pyrimidin-3-yl]met- hanones".

Company Profile

0.14.12

Epstein; Joseph William - Monroe NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
(-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor Grant 7,098,230 - Lippa , et al. August 29, 2	2006-08-29
(-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor Grant 7,081,471 - Lippa , et al. July 25, 2	2006-07-25
(-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor Grant 7,041,835 - Lippa , et al. May 9, 2	2006-05-09
2-pyridinyl[7-(substituted-pyridin-4-yl) pyrazolo[1,5-a]pyrimidin-3-yl]met- hanones App 20050245517 - Skolnick, Phil ; et al.	2005-11-03
3-substituted-3-(substitutedsulfonyl or sulfanyl) pyrrolidine-2,5-diones useful for inhibition of farnesyl-protein transferase Grant 6,949,661 - Epstein , et al. September 27, 2	2005-09-27
3-Substituted-3-(substitutedsulfonyl or sulfanyl)pyrrolidine-2,5-diones useful for inhibition of farnesyl-protein transferase Grant 6,861,445 - Epstein , et al. March 1, 2	2005-03-01
5-(arylsulfonyl)-,5-(arylsulfinyl), and 5-(arylsulfanyl)-thiazolidine-2,4-diones useful for inhibition of farnesyl-protein transferase Grant 6,784,184 - Epstein , et al. August 31, 2	2004-08-31
(-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor App 20040157870 - Lippa, Arnold Stan ; et al.	2004-08-12
(-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor App 20040157869 - Lippa, Arnold Stan ; et al.	2004-08-12
(-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor App 20040157908 - Lippa, Arnold Stan ; et al.	2004-08-12
3-substituted-3-(substitutedsulfonyl or sulfanyl)pyrrolidine-2,5-diones useful for inhibition of farnesyl-protein transferase Grant 6,740,675 - Epstein , et al. May 25, 2	2004-05-25
(-)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor Grant 6,716,868 - Lippa , et al. April 6, 2	2004-04-06
5-(Substituted)-5-(substitutedsulfonyl or sulfanyl) thiazolidine-2,4-diones useful for inhibition of farnesyl-protein transferase Grant 6,716,862 - Salaski , et al. April 6, 2	2004-04-06
3-Substituted-3-(substitutedsulfonyl or sulfanyl)pyrrolidine-2,5-diones useful for inhibition of farnesyl-protein transferase App 20040063777 - Epstein, Joseph William ; et al.	2004-04-01
3-substituted-3-(substitutedsulfonyl or sulfanyl) pyrrolidine-2,5-diones useful for inhibition of farnesyl-protein transferase App 20040063971 - Epstein, Joseph William ; et al.	2004-04-01
(-)-1-(3,4-DichlorophenyI)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor App 20030181508 - Lippa, Arnold Stan ; et al.	2003-09-25
Method of using 5-(arysulfonyl)-, 5-(arylsulfanyl)-and 5-(arylsulfanyl)thiazolidine-2,4-diones for inhibition of farnesyl-protein transferase Grant 6,605,628 - Ayral-Kaloustian , et al. August 12, 2	2003-08-12
5-(arylsulfonyl)-,5-(arylsulfinyl), and 5-(arylsulfanyl)-thiazolidine-2,4-- diones useful for inhibition of farnesyl-protein transferase App 20030149063 - Epstein, Joseph William ; et al.	2003-08-07
Method of using 5-(arysulfonyl)-, 5-(arylsulfanyl)-and 5-(arylsulfanyl)thiazolidine-2,4-diones for inhibition of farnesyl-protein transferase App 20030144301 - Ayral-Kaloustian, Semiramis ; et al.	2003-07-31
(-)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake Grant 6,569,887 - Lippa , et al. May 27, 2	2003-05-27
5-(Substituted)-5-(substitutedsulfonyl or sulfanyl) thiazolidine-2,4-diones useful for inhibition of farnesyl-protein transferase App 20030096849 - Salaski, Edward James ; et al.	2003-05-22
3-Substituted-3-(substitutedsulfonyl or sulfanyl)pyrroldine-2,5-diones useful for inhibition of farnesyl-protein transferase App 20030083364 - Epstein, Joseph William ; et al.	2003-05-01
(-)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitor App 20030045567 - Lippa, Arnold Stan ; et al.	2003-03-06
(+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as an anti-depressant agent Grant 6,372,919 - Lippa , et al. April 16, 2	2002-04-16
Use of 1-(substitutedphenyl)-3-azabicyclo[3.1.0]hexanes for the treatment of chemical dependencies Grant 6,204,284 - Beer , et al. March 20, 2	2001-03-20
Process for resolving cis-1-substituted phenyl-1,2-cyclopropanedicarboxylic acids Grant 4,118,417 - Epstein October 3, 1	1978-10-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.